Your browser doesn't support javascript.
loading
Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL.
Kampen, Kim R; Sulima, Sergey O; Verbelen, Benno; Girardi, Tiziana; Vereecke, Stijn; Fancello, Laura; Rinaldi, Gianmarco; Verbeeck, Jelle; Op de Beeck, Joyce; Uyttebroeck, Anne; Meijerink, Jules P P; Moorman, Anthony V; Harrison, Christine J; Spincemaille, Pieter; Cools, Jan; Cassiman, David; Fendt, Sarah-Maria; Vermeersch, Pieter; De Keersmaecker, Kim.
Afiliação
  • Kampen KR; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Sulima SO; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Verbelen B; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Girardi T; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Vereecke S; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Fancello L; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Rinaldi G; Laboratory of Cellular Metabolism and Metabolic Regulation, Center for Cancer Biology, VIB, Leuven, Belgium.
  • Verbeeck J; Department of Oncology, Laboratory of Cellular Metabolism and Metabolic Regulation, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Op de Beeck J; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Uyttebroeck A; Department of Oncology, Laboratory for Disease Mechanisms in Cancer, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Meijerink JPP; Department of Pediatric Oncology & Hematology, University Hospitals Leuven, Leuven, Belgium.
  • Moorman AV; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Harrison CJ; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK.
  • Spincemaille P; Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK.
  • Cools J; Department of Gastroenterology-Hepatology and Metabolic Center, University Hospitals Leuven, Leuven, Belgium.
  • Cassiman D; Laboratory of Molecular Biology of Leukemia, Center for Human Genetics, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Fendt SM; Laboratory of Molecular Biology of Leukemia, Center for Cancer Biology, VIB, Leuven, Belgium.
  • Vermeersch P; Department of Gastroenterology-Hepatology and Metabolic Center, University Hospitals Leuven, Leuven, Belgium.
  • De Keersmaecker K; Laboratory of Cellular Metabolism and Metabolic Regulation, Center for Cancer Biology, VIB, Leuven, Belgium.
Leukemia ; 33(4): 1055-1062, 2019 Apr.
Article em En | MEDLINE | ID: mdl-30850735
ABSTRACT
Following the publication of this article, the authors noted that Dr Laura Fancello was not listed among the authors. The corrected author list is given below. Additionally, the following was not included in the author contribution statement 'L.F. analyzed RNA sequencing data'.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article